Disclosed herein is at least one cyclopropyl amide derivative of formula I, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative of formula I disclosed herein, and at least one method of using at least one cyclopropyl amide derivative of formula I disclosed herein, for treating at least one histamine H3 receptor associated condition therewith.
